Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Polydefkis

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Plos One|November 9, 2013
Cutaneous collateral axonal sprouting re-innervates the skin component and restores sensation of denervated Swine osteomyocutaneous alloflapsZuhaib Ibrahim, Gigi Ebenezer, Joani M Christensen, et al.
The American Journal of Gastroenterology|June 24, 2024
Joint Hypermobility, Autonomic Dysfunction, Gastrointestinal Dysfunction, and Autoimmune Markers: Clinical Associations and Response to Intravenous Immunoglobulin TherapyPankaj J Pasricha, Megan McKnight, Luisa Villatoro, et al.
JAMA Neurology|January 13, 2025
Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy: A Randomized Clinical Trial With Open-Label ExtensionDavid Adams, Jonas Wixner, Michael Polydefkis, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 14, 2025
A comparison of single versus combination mechanism treatment for transthyretin amyloid cardiomyopathyVrinda Gupta, Lisa R Yanek, Bairavi Shankar, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|April 2, 2015
Characterization of Vestibulopathy in Individuals with Type 2 Diabetes MellitusBryan K Ward, Angela Wenzel, Rita R Kalyani, et al.
Neurology|October 22, 2020
Neurofilament Light Chain as a Biomarker of Hereditary Transthyretin-Mediated AmyloidosisSimina Ticau, Gautham V Sridharan, Shira Tsour, et al.
Orphanet Journal of Rare Diseases|July 10, 2020
A phase II, open-label, extension study of long-term patisiran treatment in patients with hereditary transthyretin-mediated (hATTR) amyloidosisTeresa Coelho, David Adams, Isabel Conceição, et al.
Muscle & Nerve|July 13, 2020
mNIS+7 and lower limb function in inotersen treatment of hereditary transthyretin-mediated amyloidosisP James B Dyck, John C Kincaid, Janice F Wiesman, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 18, 2024
Effects of eplontersen on symptoms of autonomic neuropathy in hereditary transthyretin-mediated amyloidosis: secondary analysis from the NEURO-TTRansform trialJonas Wixner, John L Berk, David Adams, et al.
Neurology|May 5, 2021
Large Mitochondrial DNA Deletions in HIV Sensory NeuropathyRicardo H Roda, David Bargiela, Weiran Chen, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Plos One|November 9, 2013
Cutaneous collateral axonal sprouting re-innervates the skin component and restores sensation of denervated Swine osteomyocutaneous alloflapsZuhaib Ibrahim, Gigi Ebenezer, Joani M Christensen, et al.
The American Journal of Gastroenterology|June 24, 2024
Joint Hypermobility, Autonomic Dysfunction, Gastrointestinal Dysfunction, and Autoimmune Markers: Clinical Associations and Response to Intravenous Immunoglobulin TherapyPankaj J Pasricha, Megan McKnight, Luisa Villatoro, et al.
JAMA Neurology|January 13, 2025
Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy: A Randomized Clinical Trial With Open-Label ExtensionDavid Adams, Jonas Wixner, Michael Polydefkis, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 14, 2025
A comparison of single versus combination mechanism treatment for transthyretin amyloid cardiomyopathyVrinda Gupta, Lisa R Yanek, Bairavi Shankar, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|April 2, 2015
Characterization of Vestibulopathy in Individuals with Type 2 Diabetes MellitusBryan K Ward, Angela Wenzel, Rita R Kalyani, et al.
Neurology|October 22, 2020
Neurofilament Light Chain as a Biomarker of Hereditary Transthyretin-Mediated AmyloidosisSimina Ticau, Gautham V Sridharan, Shira Tsour, et al.
Orphanet Journal of Rare Diseases|July 10, 2020
A phase II, open-label, extension study of long-term patisiran treatment in patients with hereditary transthyretin-mediated (hATTR) amyloidosisTeresa Coelho, David Adams, Isabel Conceição, et al.
Muscle & Nerve|July 13, 2020
mNIS+7 and lower limb function in inotersen treatment of hereditary transthyretin-mediated amyloidosisP James B Dyck, John C Kincaid, Janice F Wiesman, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 18, 2024
Effects of eplontersen on symptoms of autonomic neuropathy in hereditary transthyretin-mediated amyloidosis: secondary analysis from the NEURO-TTRansform trialJonas Wixner, John L Berk, David Adams, et al.
Neurology|May 5, 2021
Large Mitochondrial DNA Deletions in HIV Sensory NeuropathyRicardo H Roda, David Bargiela, Weiran Chen, et al.
Pageof 9